Adventris Pharmaceuticals
A biotechnology company focusing on cancer immunotherapy
Adventris Pharmaceuticals is a biotechnology company focused on cancer immunotherapy research and development. The company appears to be in an early stage, with minimal public-facing information available on its website. It is open to partnership opportunities and can be contacted directly for more information.
The company develops cancer immunotherapy solutions, though specific mechanisms or products are not detailed on the site.
potential partners, investors, and researchers in oncology and biotech
Background.
- Status
- unknown
- Business model
- unknown
- Company
- Adventris Pharmaceuticals
Contact
Similar projects.
Editorial take on the space this project sits in — momentum signals, adjacent moves, our call on whether the wedge is real. Get pinged when we publish a new read or when the landscape shifts.
Have a take on this space?
Tell us what you’d build differently, where you think the incumbents miss, or what we’ve gotten wrong about this project. Comments + reactions are coming soon.